Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2021 / Cilt: 31 - Sayı: 1

A Novel Laboratory Marker for Hepatosteatosis:Mean Platelet Volume to Lymphocyte Count Ratio

Hepatosteatozda Yeni Bir Laboratuvar Belirteci: Ortalama Trombosit Hacmi/Lenfosit Oranı

Pages
80–83
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: The median MPVLRs of the HS and control groups were 4.3% (2.1) and 3.6% (1.7), respectively (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Amaç: Hepatosteatosis (HS) is defined as accumulation of fat in liver reaching to an amount of at least 5% of liverweight.
📊
Key Findings & Data:We also investigated the correlation between CRP and MPVLRMethods: The data of the patients with HS who were admitted to internal medicine outpatient clinics of our insti tution between 2018 December and 2019 December were enrolled into the study.
💡
Conclusion & Impact:Results: The median MPVLRs of the HS and control groups were 4.3% (2.1) and 3.6% (1.7), respectively (p
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Abstract

Amaç: Hepatosteatosis (HS) is defined as accumulation of fat in liver reaching to an amount of at least 5% of liverweight. Not just mean platelet volume (MPV), but also MPV to lymphocyte ratio (MPVLR) has been introduced asa marker in inflammatory and metabolic conditions. We aimed to compare MPVLR values of patients with hepa tosteatosis with those of healthy controls. We also investigated the correlation between CRP and MPVLRMethods: The data of the patients with HS who were admitted to internal medicine outpatient clinics of our insti tution between 2018 December and 2019 December were enrolled into the study. The MPVLR were calculatedusing MPV/lymphocyte formula. Results: The median MPVLRs of the HS and control groups were 4.3% (2.1) and 3.6% (1.7), respectively (p

Özet

Objective: Hepatosteatoz (HS), karaciğerde en az %5 kuru ağırlığa denk gelecek şekilde yağ birikmesidir. SadeceOrtalama trombosit hacmi (MPV) değil, aynı zamanda ortalama trombosit hacmi/lenfosit oranı (MPVLR) metabo lik ve enflamatuvar durumların bir belirteci olarak bildirilmektedir. Bu çalışmamızda hepatosteatozlu hastalarınMPVLR değerini, sağlıklı kontrol grubuyla karşılaştırmayı amaçladık. Ayrıca CRP ile MPVLR arasındaki korelasyonuaraştırdık. Yöntem: Kurumumuz iç hastalıkları polikliniklerine 2018 Aralık-2019 Aralık tarihleri arasında başvuran HS’lu hasta lar çalışmaya alındı. MPVLR, MPV/Lenfosit formülü ile hesaplandı. Bulgular: HS ve kontrol gruplarının medyan MPVLR değeri sırasıyla %4.3 (2.1) ve %3.6 (1.7) idi (p

🔖

Cite This Article

KURTKULAĞI, Ö., BİLGEN, S. (2022). A Novel Laboratory Marker for Hepatosteatosis:Mean Platelet Volume to Lymphocyte Count Ratio. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 31 - Sayı: 1, 80–83. https://ajindex.com/articles/558062

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Nassir F, Rector RS, Hammoud GM, Ibdah JA. Pathogenesis and Prevention of Hepatic Steatosis. Gastroenterology & Hepatology. 2015;11:167-75
  2. Vermeire S, Van Assche G, Rutgeerts P. C-reactive protein as a marker for inflammatory bowel disease. Inflammatory Bowel Diseases. 2004;10:661-5. [CrossRef] 3. Sit M, Aktas G, Yilmaz EE, Hakyemez IN, Alcelik A, Kucukbayrak A. Platelet parameters in hepatic hydatid cysts. International Journal of Inflammation. 2013;2013:593273. [CrossRef] 4. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, et al. Mean platelet volume: a useful marker of inflammatory bowel disease activity. The American Journal of Gastroenterology 2001;96:776-81. [CrossRef] 5. Aktas G, Cakiroglu B, Sit M, et al. Mean platelet volume: a simple indicator of chronic prostatitis. Acta Medica Mediterranea. 2013;29:551-4
  3. Ulasli SS, Ozyurek BA, Yilmaz EB, Ulubay G. Mean platelet volume as an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease. Polskie Archiwum Medycyny Wewnetrznej. 2012;122:284-90. [CrossRef] 7. Aktas G, Sit M, Tekce H, et al. Mean platelet volume in nasal polyps. The West Indian Medical Journal. 2013;62:515-8. [CrossRef] 8. Chu SG, Becker RC, Berger PB, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. Journal of thrombosis and haemostasis: JTH. 2010;8:148-56. [CrossRef] 9. Cakir L, Aktas G, Enginyurt O, Cakir SA. Mean platelet volume increases in type 2 diabetes mellitus independent of HbA1c level. Acta Medica Mediterranea. 2014;30:425-8
  4. Gasparyan AY, Stavropoulos-Kalinoglou A, Toms TE, Douglas KM, Kitas GD. Association of mean platelet volume with hypertension in rheumatoid arthritis. Inflammation & Allergy Drug Targets. 2010;9:45-50. [CrossRef] 11. Aktas G, Alcelik A, Tekce BK, Tekelioglu V, Sit M, Savli H. Red cell distribution width and mean platelet volume in patients with irritable bowel syndrome. Przeglad Gastroenterologiczny. 2014;9:160-3. [CrossRef] 12. Jaremo P, Sandberg-Gertzen H. Platelet density and size in inflammatory bowel disease. Thrombosis and Haemostasis. 1996;75:560-1. [CrossRef] 13. Cakir L, Aktas G, Mercimek OB, Enginyurt O, Kaya Y, Mercimek K. Are red cell distribution width and mean platelet volume associated with rheumatoid arthritis? 2016
  5. Vizioli L, Muscari S, Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. International Journal of Clinical Practice. 2009